On March 7th, the company announced that it had signed a contract with the Ministry of Health and Welfare for the development and operation of a new hospital. 24}}

On March 7, Jichen Biologicals completed the signing of a strategic cooperation agreement with Luoyang Fudao Biotechnology Co. In the future, the three parties will carry out in-depth cooperation on cell culture amplification process from laboratory to production scale, and through the complementary advantages of each party, we will provide customers with one-stop technological solutions for the selection of carriers, equipment configuration, and the selection of routine consumables required for suspension/applied-wall cell culture, so as to jointly promote the development of the life sciences industry.

Since its establishment in 2017, Jichen Bio has taken process automation and control technology as the core to provide pharmaceutical companies with advanced and customized production systems in compliance with GMP requirements. As a pharmaceutical equipment integrator, Jichen Bio has rich experience in the design of foreign pharmaceutical production systems, in which we have developed and produced a series of fully automated bioreactors on our own, covering from laboratory glass reactors to production-grade stainless steel reactors. We have carried out deep cooperation and accumulated rich experience in bioreactor and automation projects.

This strategic cooperation, Jichen Bio and Fudo Bio, which is committed to high-end cell culture consumables/laboratory consumablesproduction, as well as , which is committed to the development and manufacturing of high-end cell culture consumables/laboratory consumables, have been working together. cell personalized media/cell culture carriers producer Saio Bio join hands together to collaborate and promote the development of a series of holistic processes for suspension/ walled cells from shaker/square flasks to production level scale-up, creating a one-stop process solution platform.